Targeting key cellular pathways that drive scarring in urological tissues to prevent and potentially reverse fibrotic changes.
Developing delivery methods that concentrate treatment at the site of fibrosis, maximizing efficacy while minimizing systemic exposure.
Exploring approaches that not only halt fibrosis but support the restoration of healthy, functional urological tissue.